Clinical Trials

Inclusion Critiera:

• Patient has a clinical diagnosis cholangiocarcinoma and under evaluation for surgical intervention with intent to cure.
• Age ≥ 18 years.

Exclusion Critieria:

• Patient has metastatic disease involving other organs (excluding lymph node).
• Patient has known primary cancer outside of the bile ducts within the last 3 years prior to blood collection (not including basal cell or squamous cell skin cancers, indolent cancer not requiring treatment within 3 years i.e. kidney, prostate or thyroid being observed).
• Patient has had surgery to completely or partially remove current target pathology.
• Patient has undergone any prior radiation therapy to target lesion prior to blood collection.
• Patient has received chemotherapy class drugs in the 3 years prior to blood collection.
• Patient has had any transplants prior to blood collection.
• Current target pathology is a recurrence.

 Exclusion Criteria: 

• No longer surgical candidate.
• Diagnosis of second primary cancer.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/22/23. Questions regarding updates should be directed to the study team contact.